Analyzing Generics Market in India 2017
The Indian pharmaceutical industry is the third biggest in the world in terms of volume. The government has actively encouraged the growth of drug manufacturing within the country and has been providing many incentives to leading global manufacturers to set up their production hubs in India. Mumbai, Hyderabad, Bangalore, Ahmedabad and Visakhapatnam are some of the leading pharmaceutical hubs in the country.
The Indian generics industry has similarly experienced robust growth in the last couple of years and generics account for over 96% of the overall pharmaceutical market in India. The Indian Government's 'Pharma Vision 2020' has been a major factor towards the growth of the generics segment in the country.
Aruvian Research presents Analyzing Generics Market in India 2017 – a comprehensive coverage of the Indian generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.
Moving on, we analyze the Generics Industry in Asia Pacific through the same parameters.
The Generics Industry in India is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.
We also include a Porter’s Five Forces analysis of the Indian Generics Industry. Generics pricing and reimbursement situation in India and trends and challenges facing the industry are analyzed.
Analysis of the major industry players in the Indian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Cipla Limited, Lupin, Mylan, Sanofi SA, Teva Pharmaceutical Industries, Aurobindo Pharma Limited, Sun Pharmaceutical Industries Ltd. and Sandoz International. This concludes this comprehensive research report from Aruvian Research.
The Indian generics industry has similarly experienced robust growth in the last couple of years and generics account for over 96% of the overall pharmaceutical market in India. The Indian Government's 'Pharma Vision 2020' has been a major factor towards the growth of the generics segment in the country.
Aruvian Research presents Analyzing Generics Market in India 2017 – a comprehensive coverage of the Indian generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.
Moving on, we analyze the Generics Industry in Asia Pacific through the same parameters.
The Generics Industry in India is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.
We also include a Porter’s Five Forces analysis of the Indian Generics Industry. Generics pricing and reimbursement situation in India and trends and challenges facing the industry are analyzed.
Analysis of the major industry players in the Indian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Cipla Limited, Lupin, Mylan, Sanofi SA, Teva Pharmaceutical Industries, Aurobindo Pharma Limited, Sun Pharmaceutical Industries Ltd. and Sandoz International. This concludes this comprehensive research report from Aruvian Research.
A. EXECUTIVE SUMMARY
B. ANALYZING THE GLOBAL GENERICS INDUSTRY
B.1 Industry Definition
B.2 Industry Overview
B.3 Industry Value & Volume Analysis
B.4 Industry Segmentation by Geography
B.5 Patent Expiries
B.6 Global Generic Industry Structure
B.7 Industry Forecast
C. GENERICS INDUSTRY IN ASIA PACIFIC
C.1 Industry Overview
C.2 Industry Value & Volume
C.3 Industry Segmentation by Geography
C.4 Industry Forecast
D. GENERICS INDUSTRY IN INDIA
D.1 Industry Overview
D.2 Industry Value & Volume
D.3 Industry Segmentation by Geography
D.4 Industry Forecast
E. GENERICS INDUSTRY IN INDIA: PORTER’S FIVE FORCES STRATEGY ANALYSIS
E.1 Introduction
E.2 Bargaining Power of Buyers
E.3 Bargaining Power of Suppliers
E.4 Competitive Rivalry in the Industry
E.5 Threat of New Entrants
E.6 Threat of Substitutes
F. PRICING & REIMBURSEMENT IN INDIA
F.1 Overview
F.2 Generics Pricing & Reimbursement Scenario
F.3 Trends & Challenges
G. MAJOR INDUSTRY PLAYERS
G.1 Cipla Limited
G.1.1 Corporate Analysis
G.1.2 Financial Analysis
G.1.3 SWOT Analysis
G.2 Lupin Limited
G.2.1 Corporate Analysis
G.2.2 Financial Analysis
G.2.3 SWOT Analysis
G.3 Mylan N.V.
G.3.1 Corporate Analysis
G.3.2 Financial Analysis
G.3.3 SWOT Analysis
G.4 Sanofi SA
G.4.1 Corporate Analysis
G.4.2 Financial Analysis
G.4.3 SWOT Analysis
G.5 Teva Pharmaceutical Industries Limited
G.5.1 Corporate Analysis
G.5.2 Financial Analysis
G.5.3 SWOT Analysis
G.6 Aurobindo Pharma Limited
G.7 Sandoz International GmbH
G.8 Sun Pharmaceutical Industries Ltd.
H. GLOSSARY OF TERMS
B. ANALYZING THE GLOBAL GENERICS INDUSTRY
B.1 Industry Definition
B.2 Industry Overview
B.3 Industry Value & Volume Analysis
B.4 Industry Segmentation by Geography
B.5 Patent Expiries
B.6 Global Generic Industry Structure
B.7 Industry Forecast
C. GENERICS INDUSTRY IN ASIA PACIFIC
C.1 Industry Overview
C.2 Industry Value & Volume
C.3 Industry Segmentation by Geography
C.4 Industry Forecast
D. GENERICS INDUSTRY IN INDIA
D.1 Industry Overview
D.2 Industry Value & Volume
D.3 Industry Segmentation by Geography
D.4 Industry Forecast
E. GENERICS INDUSTRY IN INDIA: PORTER’S FIVE FORCES STRATEGY ANALYSIS
E.1 Introduction
E.2 Bargaining Power of Buyers
E.3 Bargaining Power of Suppliers
E.4 Competitive Rivalry in the Industry
E.5 Threat of New Entrants
E.6 Threat of Substitutes
F. PRICING & REIMBURSEMENT IN INDIA
F.1 Overview
F.2 Generics Pricing & Reimbursement Scenario
F.3 Trends & Challenges
G. MAJOR INDUSTRY PLAYERS
G.1 Cipla Limited
G.1.1 Corporate Analysis
G.1.2 Financial Analysis
G.1.3 SWOT Analysis
G.2 Lupin Limited
G.2.1 Corporate Analysis
G.2.2 Financial Analysis
G.2.3 SWOT Analysis
G.3 Mylan N.V.
G.3.1 Corporate Analysis
G.3.2 Financial Analysis
G.3.3 SWOT Analysis
G.4 Sanofi SA
G.4.1 Corporate Analysis
G.4.2 Financial Analysis
G.4.3 SWOT Analysis
G.5 Teva Pharmaceutical Industries Limited
G.5.1 Corporate Analysis
G.5.2 Financial Analysis
G.5.3 SWOT Analysis
G.6 Aurobindo Pharma Limited
G.7 Sandoz International GmbH
G.8 Sun Pharmaceutical Industries Ltd.
H. GLOSSARY OF TERMS
LIST OF FIGURES
Figure 1: Historical Revenues of Leading Generic Companies (in USD Million), 2008-2009
Figure 2: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Figure 3: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Figure 4: Global Generics Market Segmentation by Geography (%), 2016
Figure 5: Revenues of Top 10 Drugs that went off Patent between 2010-2014 (in USD Million)
Figure 6: Market Share of Leading Generic Companies Worldwide (%), 2016
Figure 7: Comparison of Revenues of Leading Generic Companies (in USD Million), 2013-2014
Figure 8: Global Generics Industry Forecast (in USD Billion), 2016-2021
Figure 9: Global Generics Industry Forecast by Volume (% of Pharma Volume), 2016-2021
Figure 10: Value of the Asia Pacific Generics Market (in USD Billion), 2012-2016
Figure 11: Volume Growth of the Asia Pacific Generics Market (%), 2012-2016
Figure 12: Share of the Asia Pacific Generics Industry by Countries (%), 2016
Figure 13: Forecast of the Asia Pacific Generics Market (in USD Billion), 2016-2021
Figure 14: Volume Forecast of the Asia Pacific Generics Market (%), 2016-2021
Figure 15: Value of the Generics Market in India (in USD Billion), 2012-2016
Figure 16: Volume Growth of the Generics Market in India (%), 2012-2016
Figure 17: Share of India in the Asia Pacific Generics Industry (%), 2016
Figure 18: Forecast of the Generics Market in India (in USD Billion), 2016-2021
Figure 19: Volume Forecast of the Generics Market in India (%), 2016-2021
Figure 20: Porter's Five Forces Strategy Analysis of the Generics Industry in India
Figure 21: Bargaining Power of Buyers in the Indian Generics Industry
Figure 22: Bargaining Power of Suppliers in the Indian Generics Industry
Figure 23: Competitive Rivalry in the Indian Generics Industry
Figure 24: Threat of New Entrants to the Indian Generics Industry
Figure 25: Threat of Substitutes to the Indian Generics Industry
Figure 26: Impacts on Drug Prices in India
Figure 27: Revenues & Profitability of Cipla Limited (in USD Million), 2011-2015
Figure 28: Revenues & Profitability of Lupin (in USD Million), 2011-2015
Figure 29: Revenues & Profitability of Sanofi SA (in USD Million), 2011-2015
Figure 30: Revenues & Profitability of Teva Pharmaceutical (in USD Million), 2011-2015
Figure 31: Revenues & Profitability of Aurobindo Pharma (in USD Million), 2011-2015
Figure 32: Revenues & Profitability of Sun Pharmaceutical (in USD Million), 2011-2015
Figure 1: Historical Revenues of Leading Generic Companies (in USD Million), 2008-2009
Figure 2: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Figure 3: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Figure 4: Global Generics Market Segmentation by Geography (%), 2016
Figure 5: Revenues of Top 10 Drugs that went off Patent between 2010-2014 (in USD Million)
Figure 6: Market Share of Leading Generic Companies Worldwide (%), 2016
Figure 7: Comparison of Revenues of Leading Generic Companies (in USD Million), 2013-2014
Figure 8: Global Generics Industry Forecast (in USD Billion), 2016-2021
Figure 9: Global Generics Industry Forecast by Volume (% of Pharma Volume), 2016-2021
Figure 10: Value of the Asia Pacific Generics Market (in USD Billion), 2012-2016
Figure 11: Volume Growth of the Asia Pacific Generics Market (%), 2012-2016
Figure 12: Share of the Asia Pacific Generics Industry by Countries (%), 2016
Figure 13: Forecast of the Asia Pacific Generics Market (in USD Billion), 2016-2021
Figure 14: Volume Forecast of the Asia Pacific Generics Market (%), 2016-2021
Figure 15: Value of the Generics Market in India (in USD Billion), 2012-2016
Figure 16: Volume Growth of the Generics Market in India (%), 2012-2016
Figure 17: Share of India in the Asia Pacific Generics Industry (%), 2016
Figure 18: Forecast of the Generics Market in India (in USD Billion), 2016-2021
Figure 19: Volume Forecast of the Generics Market in India (%), 2016-2021
Figure 20: Porter's Five Forces Strategy Analysis of the Generics Industry in India
Figure 21: Bargaining Power of Buyers in the Indian Generics Industry
Figure 22: Bargaining Power of Suppliers in the Indian Generics Industry
Figure 23: Competitive Rivalry in the Indian Generics Industry
Figure 24: Threat of New Entrants to the Indian Generics Industry
Figure 25: Threat of Substitutes to the Indian Generics Industry
Figure 26: Impacts on Drug Prices in India
Figure 27: Revenues & Profitability of Cipla Limited (in USD Million), 2011-2015
Figure 28: Revenues & Profitability of Lupin (in USD Million), 2011-2015
Figure 29: Revenues & Profitability of Sanofi SA (in USD Million), 2011-2015
Figure 30: Revenues & Profitability of Teva Pharmaceutical (in USD Million), 2011-2015
Figure 31: Revenues & Profitability of Aurobindo Pharma (in USD Million), 2011-2015
Figure 32: Revenues & Profitability of Sun Pharmaceutical (in USD Million), 2011-2015
LIST OF TABLES
Table 1: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Table 2: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Table 3: Global Generics Industry, Segmentation by Geography (in USD Billion), 2016
Table 4: Global Generics Industry Forecast (in USD Billion), 2016-2021
Table 5: Global Generics Industry Forecast by Volume & Percentage Growth (% of Pharma Volume), 2016-2021
Table 6: Value of the Asia Pacific Generics Market (in USD Billion), 2012-2016
Table 7: Volume Growth of the Asia Pacific Generics Market (%), 2012-2016
Table 8: Share of the Asia Pacific Generics Industry by Countries (% & USD Billion), 2016
Table 9: Forecast of the Asia Pacific Generics Market (in USD Billion), 2016-2021
Table 10: Volume Forecast of the Asia Pacific Generics Market (%), 2016-2021
Table 11: Value of the Generics Market in India (in USD Billion), 2012-2016
Table 12: Volume Growth of the Generics Market in India (%), 2012-2016
Table 13: Share of India in the Asia Pacific Generics Industry (in USD Billion & %), 2016
Table 14: Forecast of the Generics Market in India (in USD Billion), 2016-2021
Table 15: Volume Forecast of the Generics Market in India (%), 2016-2021
Table 16: Drug Prices in Jan Aushadhi Shops in India Compared to Market Prices
Table 17: Key Financials of Cipla Limited (in USD Million), 2011-2015
Table 18: Key Financials of Lupin (in USD Million), 2011-2015
Table 19: Key Financials of Sanofi SA (in USD Million), 2011-2015
Table 20: Key Financials of Teva Pharmaceutical (in USD Million), 2011-2015
Table 21: Key Financials of Aurobindo Pharma (in USD Million), 2011-2015
Table 22: Key Financials of Sun Pharmaceutical (in USD Million), 2011-2015
Table 1: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Table 2: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Table 3: Global Generics Industry, Segmentation by Geography (in USD Billion), 2016
Table 4: Global Generics Industry Forecast (in USD Billion), 2016-2021
Table 5: Global Generics Industry Forecast by Volume & Percentage Growth (% of Pharma Volume), 2016-2021
Table 6: Value of the Asia Pacific Generics Market (in USD Billion), 2012-2016
Table 7: Volume Growth of the Asia Pacific Generics Market (%), 2012-2016
Table 8: Share of the Asia Pacific Generics Industry by Countries (% & USD Billion), 2016
Table 9: Forecast of the Asia Pacific Generics Market (in USD Billion), 2016-2021
Table 10: Volume Forecast of the Asia Pacific Generics Market (%), 2016-2021
Table 11: Value of the Generics Market in India (in USD Billion), 2012-2016
Table 12: Volume Growth of the Generics Market in India (%), 2012-2016
Table 13: Share of India in the Asia Pacific Generics Industry (in USD Billion & %), 2016
Table 14: Forecast of the Generics Market in India (in USD Billion), 2016-2021
Table 15: Volume Forecast of the Generics Market in India (%), 2016-2021
Table 16: Drug Prices in Jan Aushadhi Shops in India Compared to Market Prices
Table 17: Key Financials of Cipla Limited (in USD Million), 2011-2015
Table 18: Key Financials of Lupin (in USD Million), 2011-2015
Table 19: Key Financials of Sanofi SA (in USD Million), 2011-2015
Table 20: Key Financials of Teva Pharmaceutical (in USD Million), 2011-2015
Table 21: Key Financials of Aurobindo Pharma (in USD Million), 2011-2015
Table 22: Key Financials of Sun Pharmaceutical (in USD Million), 2011-2015
